Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
about
Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds.Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs.CGRP and migraine: could PACAP play a role too?Where does a migraine attack originate? In the brainstem.Therapeutic prospects for migraine: can paradise be regained?Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.PACAP38: Emerging Drug Target in Migraine and Cluster Headache.Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine.Role of VIP/PACAP in primary headaches.Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method.PACAP-induced migraine: a possible CNS effect?Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.PACAP and its receptors in cranial arteries and mast cells.PACAP38 in human models of primary headaches.Protective effects of PACAP in ischemia.Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.PACAP38 and PAC receptor blockade: a new target for headache?
P2860
Q33573290-036DC769-B968-4DF3-AC56-28A4A3741165Q36994462-6405962F-FAC7-4284-8D69-26F67D815FE2Q37384128-405E7C5C-5C60-47C3-B706-51E1EFBAD077Q37994597-0BFB89B2-20D6-4216-BCF5-2CA85A17D34BQ38392414-B909E12F-2266-4762-86EE-3FF52A0491C0Q38794015-AA7414AA-D3A1-4FC4-9FB3-57E8758BDBBCQ39255351-4716F4CC-4251-4C4F-9D04-65D8E8259D2DQ39293515-35B197E5-CB88-40E9-81E2-1958FC34FE1AQ40454917-0609EBF9-4074-4E1A-93B0-D046A8E14FA2Q44772355-2603EBB6-FDA3-4843-90AD-1946E685440BQ47409983-B2661C96-88DA-4BCD-A206-201EA0CC2ED0Q48034068-F94903AE-5019-46F5-A6A5-78BC4D762E69Q48273446-37463E38-53B1-4BA5-9AA0-F14E25EA447DQ48660384-575A910A-1BFD-4EC0-A30E-E23D804A9631Q49721275-6EA541F1-3853-4E0C-AD28-C61D58C9A90DQ49825872-C31729E6-DF6D-4962-9594-1D4876D9F939Q49907816-6C7CE28A-E12C-41BE-B5A7-D1070F4B88D9Q52368754-8132D397-0507-468A-B424-BC3B21879BCBQ55004700-06C224A6-BD68-47E5-9DC1-234DEC1161A1Q58797905-0FA82EE6-18C0-4B6B-873C-50F9CDBEDC4A
P2860
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
description
im Juli 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2010
@uk
name
Pharmacological characterizati ...... meningeal and coronary artery
@en
Pharmacological characterizati ...... meningeal and coronary artery
@nl
type
label
Pharmacological characterizati ...... meningeal and coronary artery
@en
Pharmacological characterizati ...... meningeal and coronary artery
@nl
prefLabel
Pharmacological characterizati ...... meningeal and coronary artery
@en
Pharmacological characterizati ...... meningeal and coronary artery
@nl
P2093
P2860
P50
P356
P1433
P1476
Pharmacological characterizati ...... meningeal and coronary artery
@en
P2093
Alexander HJ Danser
Antoinette MaassenVanDenBrink
Antoon J van den Bogaerdt
Carlos M Villalón
Clemens MF Dirven
Kayi Y Chan
René de Vries
Saurabh Gupta
P2860
P304
P356
10.1177/0333102410375624
P407
P577
2010-07-05T00:00:00Z